Phase 1/2CompletedAge-related condition

Mesenchymal Stem Cells in Critical Limb Ischemia

A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intramuscular ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Critical Limb Ischemia (Cli)

Sponsor
Stempeutics Research Pvt Ltd (Industry)
Enrollment
20 enrolled
Conditions
Critical Limb Ischemia
Interventions
mesenchymal stem cells; Plasmalyte A
Ages
adults
Registry
NCT00883870

Full record on ClinicalTrials.gov

From the registry

This clinical trial aims to study the safety and efficacy of adult mesenchymal stem cells in critical limb ischemia.

Primary outcomes

  • AE and symptomatic relief

History

  1. Last registry update

  2. Study completion

  3. Primary completion

  4. Registered

  5. Started